Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M340Revenue $M93.5Net Margin (%)-36.3Altman Z-Score2.5
Enterprise Value $M196EPS $1.0Operating Margin %-36.6Piotroski F-Score5
P/E(ttm)5.6Beneish M-Score0.9Pre-tax Margin (%)-36.3Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsN
Price/Sales3.65-y EBITDA Growth Rate %--Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-26.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M42.8ROIC % (ttm)-459.6Gross Margin Increase y-yN

Gurus Latest Trades with VNDA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VNDAJohn Paulson 2015-06-30 Reduce$9.09 - $13.42
($10.76)
$ 7.94-26%Reduce -0.09%3,946,500
VNDAJohn Paulson 2015-03-31 Add0.02%$8.99 - $14.58
($11.3)
$ 7.94-30%Add 8.97%3,950,000
VNDAJohn Paulson 2014-06-30 Add0.12%$9.7 - $16.96
($13.27)
$ 7.94-40%Add 129.80%3,200,000
VNDAJohn Paulson 2014-03-31 Buy 0.11%$10.5 - $18.71
($14.13)
$ 7.94-44%New holding1,392,500
VNDAFirst Eagle Investment 2013-09-30 Sold Out -0.02%$8.05 - $13.031
($10.72)
$ 7.94-26%Sold Out0
VNDAFirst Eagle Investment 2013-06-30 Reduce-0.01%$3.93 - $13
($6.73)
$ 7.9418%Reduce -48.99%975,000
VNDAFirst Eagle Investment 2012-12-31 Add0.01%$3.03 - $4.16
($3.54)
$ 7.94124%Add 43.16%1,911,452
VNDAFirst Eagle Investment 2010-03-31 Add0.04%$10.01 - $12.38
($10.94)
$ 7.94-27%Add 111.12%752,375
VNDAFirst Eagle Investment 2009-12-31 Buy 0.04%$9.59 - $11.84
($10.79)
$ 7.94-26%New holding356,375
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VNDA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VNDA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Polymeropoulos Mihael HristosPresident and CEO 2016-01-04Sell21,353$8.96-11.38view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2016-01-04Sell9,564$8.96-11.38view
Baroldi PaoloSVP & Chief Medical Officer 2016-01-04Sell12,380$8.96-11.38view
Flynn James E 2015-12-16Buy11,170$8.97-11.48view
Flynn James E 2015-12-11Buy1,201,364$8.38-5.25view
Flynn James E 2015-12-11Buy425,982$8.6-7.67view
Polymeropoulos Mihael HristosPresident and CEO 2015-09-10Sell131,739$12.68-37.38view
Polymeropoulos Mihael HristosPresident and CEO 2015-05-22Sell186,395$10.36-23.36view
Polymeropoulos Mihael HristosPresident and CEO 2015-03-10Sell21,900$10.53-24.6view
Kelly James PatrickSVP, CFO, Sec & Treasurer 2015-03-10Sell12,450$10.53-24.6view

Quarterly/Annual Reports about VNDA:

    News about VNDA:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Cameron International, Envision Healthcare Holdings, Vanda Pharmaceutica Sep 20 2015 
    Weekly CEO Sells Highlight: Walker & Dunlop, Arista Networks, Vanda Pharmaceuticals, and Synopsys May 31 2015 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Best Performing Gurus of Past Six Months are John Paulson, First Eagle and Michael Price Jun 11 2013 
    Vanda: This Company Has Great Assets But No Profits Jan 21 2012 
    Vanda Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
    Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
    Vanda Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
    Vanda Pharmaceuticals Inc. (VNDA) Acting CFO/Treasurer Stephanie Rast Irish sells 20,000 Shares Feb 23 2010 
    Preserving Value: The Case for Voluntary Liquidation Jan 17 2010 

    More From Other Websites
    Edited Transcript of VNDA earnings conference call or presentation 10-Feb-16 9:30pm GMT Feb 11 2016
    Vanda reports 4Q loss Feb 10 2016
    Vanda reports 4Q loss Feb 10 2016
    Vanda reports 4Q loss Feb 10 2016
    Vanda Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today Feb 10 2016
    VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 10 2016
    4:07 pm Vanda Pharma beats by $0.04, reports revs in-line (Pre-announced 1/11); reaffirms FY16... Feb 10 2016
    Vanda Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results Feb 10 2016
    Q4 2015 Vanda Pharmaceuticals Inc Earnings Release - After Market Close Feb 10 2016
    VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Feb 04 2016
    Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day Feb 01 2016
    Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day Feb 01 2016
    Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2015 Financial Results on February... Jan 22 2016
    Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2015 Financial Results on February... Jan 22 2016
    Edited Transcript of VNDA earnings conference call or presentation 19-Feb-15 3:00pm GMT Jan 19 2016
    Biotechnology Equities Scrutiny -- Advaxis, Raptor Pharma, Vanda Pharma, and Infinity Pharma Jan 14 2016
    Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2015 Results and 2016... Jan 11 2016
    VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 11 2016
    Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2015 Results and 2016... Jan 11 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK